BeStock  
Markets › Compare › LXRX vs SANA

LXRX vs SANA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
LXRX · Lexicon Pharmaceuticals$1.76 ▲ 0.57%
SANA · Sana Biotechnology$2.72 ▼ 1.09%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

5482111139167Oct 9, '25Apr 9, '26Oct 7, '26
  • LXRX +7.3%
  • SANA -38.9%

Head to head

MetricLXRXSANA
Price$1.76$2.72
Change today▲ 0.57%▼ 1.09%
Market cap$783.12M$814.26M
Return, 3 months-21.8%-30.8%
Return, year to date+53.0%-33.2%
Return, 1 year+23.1%-40.0%
P/E (TTM)-11.0-3.6
P/B4.55.3
P/E percentile vs own 5y12th50th
Dividend yield––
Revenue growth (YoY, latest qtr)-97.6%–
Net profit growth (YoY)-1,077.1%+32.2%
Gross margin99.1%–
Operating margin-131.4%–
Net margin-147.4%–
Return on equity-40.2%-152.9%
Analyst target vs. price+228.4%+194.1%
Analyst buy share100%100%
RSI (14)3332
30-day volatility51.5%61.2%
Max drawdown, 1 year-34.1%-54.7%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • SANA is the largest of the group by market value.
  • LXRX has returned the most over the past year.
  • LXRX carries the lowest trailing P/E.
  • LXRX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top